<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Amylin Pharmaceuticals Inc. | Company News & Executive Profiles - AMLN | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/amylin+pharmaceuticals+inc..html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Amylin Pharmaceuticals Inc.]]></description>
	<s:counts start="0" returned="10" found="45" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Amylin Pharma: Calls Ride the Rally]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F170655-amylin-pharma-calls-ride-the-rally%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[optionMONSTER submits:  Amylin Pharmaceuticals AMLN is roaring back from a four-month low today after signing a marketing deal with Japan's Takeda Pharmaceutical. by optionMONSTER]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 02 Nov 2009 12:52:27 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/optionmonster.html"><![CDATA[optionMONSTER]]></category>
		<category domain="http://resources.bnet.com/topic/amylin+pharmaceuticals+inc..html"><![CDATA[Amylin Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMLN</category>
		<category domain="tickers">AMLN</category>
	</item>
	<item>
		<title><![CDATA[Amylin Pharmaceuticals, Inc. Q3 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-354547.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator  Operator Instructions Your first question comes from Cory Kasimov from J.P. Morgan. Mona Nilsson - J.P. Morgan This is actually Mona for Cory.  My first question is actually on the 120-day safety update.  I was wondering if you are in a position to share...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 20 Oct 2009 16:37:10 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/j.p.+morgan+chase+%2526+co..html"><![CDATA[J.P. Morgan Chase & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/therapy.html"><![CDATA[Therapy]]></category>
		<category domain="http://resources.bnet.com/topic/analysis.html"><![CDATA[Analysis]]></category>
		<category domain="http://resources.bnet.com/topic/amylin+pharmaceuticals+inc..html"><![CDATA[Amylin Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMLN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">JPM</category>
		<category domain="tickers">AMLN,JPM</category>
	</item>
	<item>
		<title><![CDATA[Amylin Pharmaceuticals, Inc. Q2 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-323852.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator instructions And our first question comes from the line of Salveen Kochnover with Collins Stewart. Please proceed. Daniel Bradbury Hello Salveen. Brent Kelly &#8211; Collins Stewart Hello. Hi, this is &#8211; sorry this is Brent Kelly in for Salveen. Can you just update us on where...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 22 Jul 2009 19:12:19 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/agency.html"><![CDATA[Agency]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/amylin+pharmaceuticals+inc..html"><![CDATA[Amylin Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/advertising+%2526+promotion.html"><![CDATA[Advertising & Promotion]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMLN</category>
		<category domain="tickers">AMLN</category>
	</item>
	<item>
		<title><![CDATA[Amylin Pharmaceuticals, Inc. Q2 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F150656-amylin-pharmaceuticals-inc-q2-2009-earnings-call-transcript%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Amylin Pharmaceuticals, Inc. AMLN   Q2 2009 Earnings Call Transcript   July 21, 2009 5:00 pm ET]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 22 Jul 2009 08:12:19 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/amylin+pharmaceuticals+inc..html"><![CDATA[Amylin Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMLN</category>
		<category domain="tickers">AMLN</category>
	</item>
	<item>
		<title><![CDATA[Why Amylin Deserves More Respect]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F150149-why-amylin-deserves-more-respect%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Dr. Stephen Leeb submits: My two most recent books, Game Over and The Coming Economic Collapse were in part inspired by the work of Joseph Tainter, author of The Collapse of Complex Societies.      Tainter makes the point that societies tend to grow in complexity as...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 21 Jul 2009 07:47:30 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/dr.+stephen+leeb.html"><![CDATA[Dr. Stephen Leeb]]></category>
		<category domain="http://resources.bnet.com/topic/amylin+pharmaceuticals+inc..html"><![CDATA[Amylin Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMLN</category>
		<category domain="tickers">AMLN</category>
	</item>
	<item>
		<title><![CDATA[Amylin, Biogen Idec Stand to Benefit from Icahn Board Victories]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F143530-amylin-biogen-idec-stand-to-benefit-from-icahn-board-victories%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Vincent Fernando submits:  Biogen Idec BIIB over-explained its drug development, then called for an extra long recess, in order to delay the shareholder vote whereby activist investor Carl Icahn was trying to repeat his success with Amylin AMLN Pharmaceuticals and add four representatives to Biogen Idec's board. It appears...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 16 Jun 2009 09:57:13 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/vincent+fernando.html"><![CDATA[Vincent Fernando]]></category>
		<category domain="http://resources.bnet.com/topic/amylin+pharmaceuticals+inc..html"><![CDATA[Amylin Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/biogen+idec+inc..html"><![CDATA[Biogen Idec Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMLN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BIIB</category>
		<category domain="tickers">AMLN,BIIB</category>
	</item>
	<item>
		<title><![CDATA[Amylin: Icahn, Eastbourne Celebrate Disposal of Chairman]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F141320-amylin-icahn-eastbourne-celebrate-disposal-of-chairman%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Todd Walker submits: Last week it was announced that activist investors Carl Icahn and Eastbourne Capital Management had successfully elected Dr. Alexander J. Denner and Dr. Kathleen Behrens, respectively, to the board of directors of Amylin Pharmaceuticals AMLN. On Tuesday, the activists received even more good news when they learned...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 04 Jun 2009 04:45:46 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/todd+walker.html"><![CDATA[Todd Walker]]></category>
		<category domain="http://resources.bnet.com/topic/amylin+pharmaceuticals+inc..html"><![CDATA[Amylin Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMLN</category>
		<category domain="tickers">AMLN</category>
	</item>
	<item>
		<title><![CDATA[Key Amylin Catalyst Expected Wednesday]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F139348-key-amylin-catalyst-expected-wednesday%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Vincent Fernando submits:  A major battle for change at Amylin Pharmaceuticals AMLN could be decided this Wednesday when the company has its annual shareholder meeting and shareholders vote for a potentially new slate of board members put forward by activist shareholders Carl Icahn and Eastbourne Capital. Nevertheless, despite heated...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Sun, 24 May 2009 05:38:23 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/vincent+fernando.html"><![CDATA[Vincent Fernando]]></category>
		<category domain="http://resources.bnet.com/topic/amylin+pharmaceuticals+inc..html"><![CDATA[Amylin Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMLN</category>
		<category domain="tickers">AMLN</category>
	</item>
	<item>
		<title><![CDATA[What Amylin's Established Drugs Are Worth Alone]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F137456-what-amylin-s-established-drugs-are-worth-alone%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Vincent Fernando submits:  Admittedly, my blog has become a bit of a war room in regard to the special situation surrounding Amylin AMLN  shares these days. I personally find it to be an extremely interesting special situation and now have exposure to the shares. A lot of analysis...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 13 May 2009 06:33:31 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/vincent+fernando.html"><![CDATA[Vincent Fernando]]></category>
		<category domain="http://resources.bnet.com/topic/amylin+pharmaceuticals+inc..html"><![CDATA[Amylin Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMLN</category>
		<category domain="tickers">AMLN</category>
	</item>
	<item>
		<title><![CDATA[Amylin: I'm Not Taking Sides]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F136947-amylin-i-m-not-taking-sides%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Mike Huckman submits:  Imagine my surprise when I got an email over the weekend from "Diabetic Investor" newsletter editor David Kliff informing me that Amylin Pharmaceuticals AMLN    is quoting me in a letter to shareholders.       AMLN is engaged in an...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 11 May 2009 10:05:05 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/mike+huckman.html"><![CDATA[Mike Huckman]]></category>
		<category domain="http://resources.bnet.com/topic/amylin+pharmaceuticals+inc..html"><![CDATA[Amylin Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMLN</category>
		<category domain="tickers">AMLN</category>
	</item>
</channel>
</rss>
